1. Signaling Pathways
  2. Anti-infection
  3. VSV

VSV

Vesicular Stomatitis Virus

Vesicular stomatitis virus (VSV), which belongs to the Vesiculovirus genus of the family Rhabdoviridae, is a well studied livestock pathogen and prototypic non-segmented, negative-sense RNA virus. Although VSV is responsible for causing economically significant outbreaks of vesicular stomatitis in cattle, horses, and swine, the virus also represents a valuable research tool for molecular biologists and virologists. Many properties of VSV make it a valuable tool for molecular virology research—such as its ability to express heterologous glycoproteins and replicate to high titers—also make it an excellent vaccine platform. In addition, the apparent seroprevalence of VSV antibodies is generally low within the human population, so there is little pre-existing immunity to the vector, and because the VSV replication cycle takes place exclusively in the cytoplasm of host cells, there is no potential for viral sequences to integrate into the host genome. As a result, recombinant VSV has emerged as a viable vaccine vector, and many recombinant VSV-based vaccines have demonstrated safety and immunogenicity in multiple pre-clinical and clinical trials.

VSV 관련 제품 (21):

Cat. No. 상품명 효과 Purity Chemical Structure
  • HY-175769
    SMU-V18
    Inhibitor
    SMU-V18 is a vesicular stomatitis virus (VSV) inhibitor, with an EC50 of 6.2 μM. SMU-V18 inhibits VSV-GFP fluorescence intensity, viral mRNA/protein expression, and progeny virus replication. SMU-V18 interferes with early viral infection stages, also effective against wild-type VSV (VSV-WT). SMU-V18 inhibits VSV-GFP in mouse tissues and prolongs survival. SMU-V18 can be used for the study of vesicular stomatitis virus (VSV) infection.
    SMU-V18